ONLINE DATABASE SEARCH -
HIV-LS-378-MEMO
1.
61199 HIV-LS-378;
EMBASE-HIV-7/9/2007
Inhibition of human immunodeficiency virus type 1 transcription by
N-aminoimidazole derivatives
Stevens, Miguel, Balzarini, Jan, Lagoja, Irene M, Noppen, Bernard,
Francois, Katrien, Van Aerschot, Arthur, Herdewijn, Piet, De Clercq, Erik, and
Pannecouque, Christophe
Virology 2007.
365(1): 220-237
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4NJX42B-4/2/d099467a1f0a71ac4ca0dd61da705268
2.
61200 HIV-LS-378;
EMBASE-HIV-7/9/2007
Anti-AIDS agents 72.
Bioisosteres (7-carbon-DCKs) of the potent anti-HIV lead DCK
Wang, Yang, Huang, Shao-Xu, Xia, Peng, Xia, Yi, Yang, Zheng-Yu, Kilgore,
Nicole, Morris-Natschke, Susan L, and Lee, Kuo-Hsiung
Bioorganic & Medicinal Chemistry Letters 2007. 17(15): 4316-4319
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NRK4G0-7/2/150e22b12692b1a3c485bcf00cdb9a96
3.
61201 HIV-LS-378;
WOS-HIV-6/29/2007
Structural Descriptors of Gp120 V3 Loop for the Prediction of Hiv-1
Coreceptor Usage
Sander, O. et al.
Plos Computational Biology 2007. 3(3): 555-564
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246191000021
4.
61202 HIV-LS-378;
WOS-HIV-6/29/2007
New Emivirine (Mkc-442)
Analogues Containing a Tetrahydronaphthalene at C-6 and Their Anti-Hiv
Activity
Therkelsen, F. et al.
Monatshefte Fur Chemie 2007.
138(5): 495-503
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246276000013
5.
61203 HIV-LS-378;
EMBASE-HIV-7/9/2007
Structural Characterization of B and non-B Subtypes of HIV-Protease:
Insights into the Natural Susceptibility to Drug Resistance
Development
Sanches, Mario, Krauchenco, Sandra, Martins, Nadia H, Gustchina, Alla,
Wlodawer, Alexander, and Polikarpov, Igor
Journal of Molecular Biology 2007. 369(4): 1029-1040
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WK7-4NBBYYK-1/2/b39fd499810efdfbc6fdb9d6a277d3cc
6.
61204 HIV-LS-378;
WOS-HIV-6/29/2007
Overcoming Hiv-1 Resistance to Rna Interference
Boden, D., Pusch, O., and Ramratnam, B.
Frontiers in Bioscience 2007. 12: 3104-3116
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246157900028
7.
61205 HIV-LS-378;
WOS-HIV-7/6/2007
Novel Nuclear Import of Vpr Promoted by Importin Alpha Is Crucial for
Human Immunodeficiency Virus Type 1 Replication in Macrophages
Nitahara-Kasahara, Y. et al.
Journal of Virology 2007.
81(10): 5284-5293
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246464200036
8.
61206 HIV-LS-378;
WOS-HIV-7/6/2007
Sphingomyelinase Restricts the Lateral Diffusion of Cd4 and Inhibits
Human Immunodeficiency Virus Fusion
Finnegan, C. et al.
Journal of Virology 2007.
81(10): 5294-5304
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246464200037
9.
61207 HIV-LS-378;
WOS-HIV-7/6/2007
Nitroimidazoies, Part 4: Synthesis and Anti-Hiv Activity of New
5-Alkylsulfanyl and 5-(4 '-Arylsulfonyl)Piperazinyl-4-Nitroimidazole
Derivatives
Al-Soud, Y. et al.
Heteroatom Chemistry 2007.
18(4): 333-340
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246375600001
10.
61208 HIV-LS-378;
WOS-HIV-7/6/2007
Synthesis and Anti-Hiv Activity of Substituted 1 2,4-Triazolo-Thiophene
Derivatives
Al-Soud, Y.
Heteroatom Chemistry 2007.
18(4): 443-448
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246375600019
11.
61209 HIV-LS-378;
WOS-HIV-7/6/2007
Discovery of Highly Potent and Selective Cxcr4 Inhibitors Using Protein
Epitope Mimetics (Pem) Technology
Lederer, A. et al.
Chimia 2007. 61 (4):
147-150
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246401500007
12.
61210 HIV-LS-378;
PUBMED-HIV-7/9/2007
Replication competent variants of human immunodeficiency virus type-2
lacking the V3 loop exhibit resistance to chemokine receptor
antagonists
Lin, G, Bertolotti-Ciarlet, A, Haggarty, B, Romano, J, McGeehan, K,
Leslie, G, d'Oliviere, AP, Huang, CC, Kwong, PD, Doms, RW, and Hoxie,
JA
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
61211 HIV-LS-378;
PUBMED-HIV-7/9/2007
N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a
rationally designed non-nucleoside reverse transcriptase inhibitor compound with
potent anti-HIV activity
Uckun, FM, Qazi, S, and Venkatachalam, T
Arzneimittelforschung 2007.
57(5): 278-85
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
61212 HIV-LS-378;
PUBMED-HIV-7/9/2007
Computational screening of inhibitors for HIV-1 integrase using a
receptor based pharmacophore model
Jaganatharaja, J and Gowthaman, R
Bioinformation
2006. 1(4):
112-7
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
61213 HIV-LS-378;
PUBMED-HIV-7/9/2007
The Nucleoside Analogs 4'C-Methyl Thymidine and 4'C-Ethyl Thymidine Block
DNA Synthesis by Wild-type HIV-1 RT and Excision Proficient NRTI Resistant RT
Variants
Boyer, PL, Julias, JG, Ambrose, Z, Siddiqui, MA, Marquez, VE, and Hughes,
SH
J Mol Biol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
61214 HIV-LS-378;
PUBMED-HIV-7/9/2007
Metabolism and Disposition in Humans of Raltegravir (MK-0518), an
Anti-AIDS Drug Targeting the HIV-1 Integrase Enzyme
Kassahun, K, McIntosh, I, Cui, D, Hreniuk, D, Merschman, S, Lasseter, K,
Azrolan, N, Iwamoto, M, Wagner, J, and Wenning, L
Drug Metab Dispos 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
61215 HIV-LS-378;
PUBMED-HIV-7/9/2007
Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by
saquinavir in combination with atazanavir or lopinavir
Dam, E, Lebel-Binay, S, Rochas, S, Thibaut, L, Faudon, JL, Thomas, CM,
Essioux, L, Hill, A, Schutz, M, and Clavel, F
Antivir Ther 2007.
12(3): 371-80
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
61216 HIV-LS-378;
PUBMED-HIV-7/9/2007
Synthesis, cytotoxicity, and antiviral activities of new neolignans
related to honokiol and magnolol
Amblard, F, Govindarajan, B, Lefkove, B, Rapp, KL, Detorio, M, Arbiser,
JL, and Schinazi, RF
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
19.
61217 HIV-LS-378;
PUBMED-HIV-7/9/2007
Phosphonated Carbocyclic 2'-Oxa-3'-azanucleosides as New Antiretroviral
Agents
Chiacchio, U, Rescifina, A, Iannazzo, D, Piperno, A, Romeo, R, Borrello,
L, Sciortino, MT, Balestrieri, E, Macchi, B, Mastino, A, and Romeo,
G
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
20.
61218 HIV-LS-378;
PUBMED-HIV-7/9/2007
In vitro selection and characterization of human immunodeficiency virus
type 2 (HIV-2) with decreased susceptibility to lopinavir
Masse, S, Lu, X, Dekhtyar, T, Lu, L, Koev, G, Gao, F, Mo, H, Kempf, D,
Bernstein, B, Hanna, GJ, and Molla, A
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
61219 HIV-LS-378;
PUBMED-HIV-7/9/2007
Synthesis and biological evaluation of
N-acetyl-beta-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in
vitro
Cheng, P, Jiang, ZY, Wang, RR, Zhang, XM, Wang, Q, Zheng, YT, Zhou, J,
and Chen, JJ
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
22.
61220 HIV-LS-378;
PUBMED-HIV-7/9/2007
Differential in vitro
inhibitory activity against HIV-1 of alpha-(1-3)- and alpha-(1-6)-D-mannose
specific plant lectins : Implication for microbicide development
Saidi, H, Nasreddine, N, Jenabian, MA, Lecerf, M, Schols, D, Krief, C,
Balzarini, J, and Belec, L
J Transl Med 2007.
5(1): 28
View Data on the NIAID Therapeutics Website
HYPERLINK:
23.
61221 HIV-LS-378;
PUBMED-HIV-7/9/2007
New 4-[(1-Benzyl-1H-indol-3-yl)carbonyl]-3-hydroxyfuran-2(5H)-ones,
beta-Diketo Acid Analogs as HIV-1 Integrase Inhibitors
Ferro, S, Barreca, ML, De Luca, L, Rao, A, Monforte, AM, Debyser, Z,
Witvrouw, M, and Chimirri, A
Arch Pharm (Weinheim) 2007.
340(6): 292-298